(Q51791653)

12 April 2018

title

Early obesity and age-related mimicry of metabolic syndrome in female mice with sex hormonal imbalances. (English)

1 reference

12 April 2018

0 references

1 reference

5

Dusica Maysinger

1 reference

12 April 2018

author name string

M Ram Sairam

1

1 reference

12 April 2018

Min Wang

2

1 reference

12 April 2018

Natalia Danilovich

3

1 reference

12 April 2018

Danesh Javeshghani

4

1 reference

12 April 2018

publication date

1 July 2006

1 reference

12 April 2018

published in

Obesity

1 reference

12 April 2018

volume

14

1 reference

12 April 2018

issue

7

1 reference

12 April 2018

page(s)

1142-1154

1 reference

12 April 2018

Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Protein tyrosine phosphatases: the quest for negative regulators of insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Medical Consequences of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Regulation of estrogen biosynthesis by human adipose cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Concentration of sex steroids in adipose tissue after menopause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The decline of androgen levels in elderly men and its clinical and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Perspectives on reproductive senescence and biological aging: studies in genetically altered follitropin receptor knockout [FORKO] mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Increased adipose tissue in male and female estrogen receptor-alpha knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Haploinsufficiency of the follicle-stimulating hormone receptor accelerates oocyte loss inducing early reproductive senescence and biological aging in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Delay in sexual maturity of the follicle-stimulating hormone receptor knockout male mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Hormone therapy: physiological complexity belies therapeutic simplicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

COX-2-derived prostacyclin confers atheroprotection on female mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Effects of Age and Obesity on Insulin Binding to Isolated Adipocytes1212

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

AdipoQ is a novel adipose-specific gene dysregulated in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Intra-abdominal obesity and metabolic risk factors: a study of young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Adipose tissue as an endocrine organ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Secretory, endocrine and autocrine/paracrine function of the adipocyte

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Inflammatory pathways and insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

The role of SOCS-3 in leptin signaling and leptin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

Aromatase-deficient (ArKO) mice accumulate excess adipose tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.131

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.131

1 reference

12 April 2018

1 reference

12 April 2018